NEW YORK : The S&P 500 and the Nasdaq ended higher, while the Dow closed lower after a choppy trading session on Thursday, as ...
Narco’s scientists doubted pharmaceutical giant Eli Lilly’s marketing, which claimed that the drug could be a highly ...
In December, the NHS spending watchdog recommended Mounjaro – also known as tirzepatide and made by Eli Lilly – for people with a body mass index (BMI) of more than 35 and at least one weight-related ...
W.G. Nunn Elementary School recently announced its 2nd Nine Weeks Honor Roll: 1st Grade Honor Roll w/Distinction: De’Monei Brantley, Keith Brown, Adelynn Brown-Murray, Malaysia Carter, Teyanna Denson, ...
LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce the ...
Eli Lilly strengthens its pipeline with AdvanCell for targeted alpha therapies and partners with OliX to advance OLX75016 for MASH and cardiometabolic diseases.
Eli Lilly has begun the week with a bang. Early Monday morning, AdvanCell and OliX Pharmaceuticals put out news that the Big ...
Eli Lilly (LLY) investors should expect fireworks this week as the pharma giant prepares to drop its bombshell Q4 2024 earnings figures before tomorrow’s bell. Given recent price action ...
Eli Lilly (NYSE:LLY) is setting the stage for a strong 2025, with its fourth-quarter results and forward guidance reflecting solid momentum. The company's adjusted earnings per share are expected ...
Eli Lilly’s momentum stems from blockbuster GLP-1 therapies (Mounjaro, Zepbound), fuelling revenue growth, long-term margin expansion, and an ethos driving America’s health focus across ...
Eli Lilly is set to report fourth-quarter earnings early Thursday, with analysts expecting rising sales and profit in the first full quarter with the company's weight-loss drugs no longer in shortage.
With a market cap of $799.5 billion, Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a leading global pharmaceutical firm renowned for its innovative contributions to healthcare.